Home LiteratureArticle Details
PMID: 11438644 Published · ppublish English Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Mutational analysis of the Cy motif from p21 reveals sequence degeneracy and specificity for different cyclin-dependent kinases.

Molecular and cellular biology ·Vol. 21 ·No. 15 ·2001-08-00 ·Pages 4868-74

Wohlschlegel JA, Dwyer BT, Takeda DY, Dutta A

Abstract

Inhibitors, activators, and substrates of cyclin-dependent kinases (cdks) utilize a cyclin-binding sequence, known as a Cy or RXL motif, to bind directly to the cyclin subunit. Alanine scanning mutagenesis of the Cy motif of the cdk inhibitor p21 revealed that the conserved arginine or leucine (constituting the conserved RXL sequence) was important for p21's ability to inhibit cyclin E-cdk2 activity. Further analysis of mutant Cy motifs showed, however, that RXL was neither necessary nor sufficient for a functional cyclin-binding motif. Replacement of either of these two residues with small hydrophobic residues such as valine preserved p21's inhibitory activity on cyclin E-cdk2, while mutations in either polar or charged residues dramatically impaired p21's inhibitory activity. Expressing p21N with non-RXL Cy sequences inhibited growth of mammalian cells, providing in vivo confirmation that RXL was not necessary for a functional Cy motif. We also show that the variant Cy motifs identified in this study can effectively target substrates to cyclin-cdk complexes for phosphorylation, providing additional evidence that these non-RXL motifs are functional. Finally, binding studies using p21 Cy mutants demonstrated that the Cy motif was essential for the association of p21 with cyclin E-cdk2 but not with cyclin A-cdk2. Taking advantage of this differential specificity toward cyclin E versus cyclin A, we demonstrate that cell growth inhibition was absolutely dependent on the ability of a p21 derivative to inhibit cyclin E-cdk2.

MeSH Terms
Alanine/chemistry Amino Acid Motifs CDC2-CDC28 Kinases Cell Cycle Cell Division Cell Separation Cyclin E/metabolism Cyclin-Dependent Kinase 2 Cyclin-Dependent Kinase Inhibitor p21 Cyclin-Dependent Kinases/metabolism Cyclins/chemistry,genetics DNA Mutational Analysis Escherichia coli/metabolism Flow Cytometry Inhibitory Concentration 50 Leucine/chemistry Mutation Papillomaviridae/genetics Peptides/metabolism Plasmids/metabolism Protein Binding Protein Serine-Threonine Kinases/metabolism Sequence Homology, Amino Acid Substrate Specificity
Chemicals
Cyclin E Cyclin-Dependent Kinase Inhibitor p21 Cyclins Peptides Protein Serine-Threonine Kinases CDC2-CDC28 Kinases Cyclin-Dependent Kinase 2 Cyclin-Dependent Kinases Leucine Alanine
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Wohlschlegel J A
Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Dwyer B T
Takeda D Y
Dutta A
References (26)
26 references, click to expand
  1. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex.
    Nature. 1996 Jul 25;382(6589):325-31 PMID: 8684460
  2. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex.
    Nature. 1995 Jul 27;376(6538):313-20 PMID: 7630397
  3. Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors.
    Mol Cell Biol. 1996 Dec;16(12):6623-33 PMID: 8943316
  4. p21CIP1 and Cdc25A: competition between an inhibitor and an activator of cyclin-dependent kinases.
    Mol Cell Biol. 1997 Aug;17(8):4338-45 PMID: 9234691
  5. Purification and analysis of CIP/KIP proteins.
    Methods Enzymol. 1997;283:230-44 PMID: 9251023
  6. Cyclin-dependent kinases: engines, clocks, and microprocessors.
    Annu Rev Cell Dev Biol. 1997;13:261-91 PMID: 9442875
  7. Analysis of cell-cycle profiles in transfected cells using a membrane-targeted GFP.
    Biotechniques. 1998 Mar;24(3):349-50, 352, 354 PMID: 9526637
  8. Tenascin-C hexabrachion assembly is a sequential two-step process initiated by coiled-coil alpha-helices.
    J Biol Chem. 1998 Apr 24;273(17):10602-8 PMID: 9553121
  9. Human CDC6/Cdc18 associates with Orc1 and cyclin-cdk and is selectively eliminated from the nucleus at the onset of S phase.
    Mol Cell Biol. 1998 May;18(5):2758-67 PMID: 9566895
  10. Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A.
    Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10453-8 PMID: 9724724
  11. Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization.
    EMBO J. 1999 Jan 15;18(2):396-410 PMID: 9889196
  12. Retinoblastoma protein contains a C-terminal motif that targets it for phosphorylation by cyclin-cdk complexes.
    Mol Cell Biol. 1999 Feb;19(2):1068-80 PMID: 9891042
  13. Interaction between cyclin-dependent kinases and human papillomavirus replication-initiation protein E1 is required for efficient viral replication.
    Proc Natl Acad Sci U S A. 1999 Jan 19;96(2):382-7 PMID: 9892642
  14. Multistep regulation of DNA replication by Cdk phosphorylation of HsCdc6.
    Proc Natl Acad Sci U S A. 1999 May 25;96(11):6193-8 PMID: 10339564
  15. Overproduction of human Myt1 kinase induces a G2 cell cycle delay by interfering with the intracellular trafficking of Cdc2-cyclin B1 complexes.
    Mol Cell Biol. 1999 Jul;19(7):5113-23 PMID: 10373560
  16. Evolving ideas about cyclins.
    Cell. 1999 Jul 23;98(2):129-32 PMID: 10428024
  17. Inhibition of cyclin-dependent kinases by p21.
    Mol Biol Cell. 1995 Apr;6(4):387-400 PMID: 7626805
  18. Cyclin-dependent kinases: inhibition and substrate recognition.
    Curr Opin Struct Biol. 1999 Dec;9(6):738-44 PMID: 10607671
  19. beta3-endonexin as a novel inhibitor of cyclin A-associated kinase.
    Biochem Biophys Res Commun. 2000 Jan 27;267(3):947-52 PMID: 10673397
  20. SSeCKS, a major protein kinase C substrate with tumor suppressor activity, regulates G(1)-->S progression by controlling the expression and cellular compartmentalization of cyclin D.
    Mol Cell Biol. 2000 Oct;20(19):7259-72 PMID: 10982843
  21. The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases.
    Nat Cell Biol. 1999 Nov;1(7):438-43 PMID: 10559988
  22. A bipartite substrate recognition motif for cyclin-dependent kinases.
    J Biol Chem. 2001 Jan 19;276(3):1993-7 PMID: 11067844
  23. Principles of CDK regulation.
    Nature. 1995 Mar 9;374(6518):131-4 PMID: 7877684
  24. Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA.
    Nature. 1995 Mar 23;374(6520):386-8 PMID: 7885482
  25. p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F.
    Genes Dev. 1995 Jul 15;9(14):1740-52 PMID: 7622038
  26. Cyclin-binding motifs are essential for the function of p21CIP1.
    Mol Cell Biol. 1996 Sep;16(9):4673-82 PMID: 8756624
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
Published
2001-08-00
Pages
4868-74
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC87195
Subset
IM
Grants
NCI NIH HHS · R01 CA089406 · United States
NCI NIH HHS · R01 CA089406-01 · United States
NCI NIH HHS · CA89406 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com